Drugs / salmeterol/fluticasone propionate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07114107 Background | Aug 2025 → Mar 2026 overdue | allergic asthma, allergic rhinitis | Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | salmeterol/fluticasone propionate | “salmeterol/fluticasone propionate (50μg/100μg) with 1 inhalation each time, twice daily.” NCT07114107 ↗ |
| Route | Inhaled | “salmeterol/fluticasone propionate (50μg/100μg) with 1 inhalation each time, twice daily” NCT07114107 ↗ |